NKX2-3 is reported to be up-regulated in intestinal tissues in CD patients [13] and VEGF showed markedly enhanced expression levels in both CD and UC tissues [16], while EDN1 showed both increased levels [17] and decreased levels in intestinal tissues from IBD patients [18]. Here, NKX2-3 is linked to inflammatory bowel disease.